operating activities 1,788 Net cash flows investing activities (2,101) Net cash flows financing activities 623 Net increase in cash and cash equivalents 310 Cash and cash equivalents at beginning of period

financial period, net cash was increased by 12.24 million Baht. This comprised of the following items: 1) Net cash received from Operating Activities totaling Baht 594.40 million Baht from the net income by

. The average collection period as at the end of this quarter was 95 days compared to 139 days as of 31 December 2018. The increase in average collection period was because of Trans.Ad Group ‘s

CMG revenues when goods are ready for transfer to customers (precisely after incubation period) and not when it has been transferred. This impacted the Company and its subsidiaries’ financial statement

recognize CMG revenues when goods are ready for transfer to customers (precisely after incubation period) and not when it has been transferred. This impacted the Company and its subsidiaries’ financial

Limited for the three months period ended March 31, 2019. And The Audited financial statement of BS Myco Biotech Company Limited for year ended December 31,2018. The calculation of transaction size (1) Book

9.05 5.71 7.77 (0.97) 14.52 Profit before income tax expenses 34.41 46.63 23.08 31.41 (11.33) 32.93 Income tax expenses 3.57 4.84 3.95 5.38 0.38 10.64 Profit for the period 30.84 41.79 19.13 26.04 (11.71

ซื้อทรัพย์สินใหม่ภำคเอกชนเห็นว่ำ ควรใช้หลักเกณฑ์ กำรอนุญำตเช่นเดียวกับกำรแปลงสภำพกอง 1 เป็น REIT แบบ 1: 1 เช่น ไม่ต้องมีที่ปรึกษำทำงกำรเงิน ไม่ม ีunderwriter และมี cooling period เพียง 1 วัน ซึ่งส ำนักงำ

cash flows financing activities 5,584 Net increase in cash and cash equivalents 5,780 Cash and cash equivalents at beginning of period 704 Cash and cash equivalents at end of period 6,484 (Translation

during Jan to May 2020 decreased by 3.2% from the usage during the same period of the previous year. Demands from industrial and business sectors dropped due to global economic slowdown as a result of